Insight ReportExpress Scripts (ESRX) 4Q15 Results: Surprise Sales Dip, Soft Outlook Coresight Research February 17, 2016 Executive Summary Express Scripts reported 4Q15 revenue of $26.2 billion, slightly below the consensus estimate of $26.5 billion and roughly flat compared to the same quarter a year ago. The company reported diluted EPS of $1.56, in line with the consensus estimate of $1.56 and up 12.2% year over year. The company narrowed its EPS guidance for FY16. The company now expects earnings in the range of $6.10–$6.28 versus previous guidance of $6.08–$6.28. The current consensus estimate is for EPS of $6.13. For 1Q16, Express Scripts expects earnings in the range of $1.18–$1.22, below the consensus of $1.28. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Innovator Profile: Gain—Autonomous AI Employees for Smarter, Faster ProcurementCanada Store Openings and Closures Tracker 2025: Bankrupt Hudson’s Bay Company Takes Total Closures Ahead of OpeningsThree Data Points We’re Watching This Week, Week 12: US Retail and Consumer LatestWeekly US and UK Store Openings and Closures Tracker 2025, Week 4: Store Closures Near 2,100 in the US
